Sarepta Therapeutics Inc (SRPT) has been in the limelight since the Ebola outbreak started. The development-stage biotech has been categorized as one of the handful of companies working on a cure for Ebola, and gained public attention in August when it announced that it possesses a shelved experimental Ebola drug; since then, Sarepta stock has risen nearly 10%.
Hey, check out all the research scientist jobs. Post your resume today!
